期刊文献+

19例成人噬血细胞综合征临床分析 被引量:5

Clinical analysis of 19 adult patients with hemophagocytic syndrome
原文传递
导出
摘要 目的:探讨成人噬血细胞综合征(HPS)的临床特点,旨在进一步提高对该病的认识。方法:回顾分析19例成人HPS的临床资料。结果:19例患者中男11例,女8例;中位发病年龄34(18~61)岁。考虑肿瘤相关5例(26.3%),感染相关5例(26.3%),结缔组织病4例(21.1%),原因不明5例(26.3%)。19例患者(100%)均有高热,14例(73.7%)表现为肝脾肿大,5例(26.3%)表现为多发浅表淋巴结肿大,3例(15.8%)出现皮疹,3例(15.8%)出现神经系统症状。19例患者均出现血清铁蛋白及血清乳酸脱氢酶升高,18例(94.7%)可见血细胞减少,14例(73.7%)血清甘油三酯水平升高,5例(26.3%)出现低纤维蛋白原血症,12例(63.2%)出现肝功能异常。4例(21.1%)EB病毒DNA滴度升高。全部患者于骨髓中发现吞噬细胞现象。全组患者8例存活,7例死亡,4例失访。19例患者的生存时间为0.3~39.8个月(中位生存时间为4.7个月),病死率36.8%。结论:HPS是一种少见疾病,其病因复杂,进展迅速,病死率高,且发病机制尚未明确,提高对HPS的认识,做出早期诊断和及时的治疗至关重要。 Objective: To investigate the clinical features of adult patients with hemophagocytic syndrome (HPS) and to improve recognition of HPS. Method: The clinical and experimental data of 19 adult patients with HPS were collected. Result: Of 19 patients, male in 11 cases, women in 8 cases, the median onset age was 34 ( 18 to 61). The initiating causes were as follows:5 cases (26.3%) with tumor,5 cases (26.3%) with infection,4 cases (21.1%) with rheumatoid diseases and 5 cases (26.3%) with unknown etiology. HPS was characterized typically by fever ( 100 % ), splenomegaly (73.7% ), hepatomegaly (26.3 %) and other features including lymph adenopathy (26.3%) ,skin rash (15.8%),and central nervous system involvement (15.8%). According to laboratory data, two or three cytopenia (94.7 % ), heperferritinemia ( 100 %), elevated lactate dehydrogenase (100 %), hypertriglyceridemia (73. 7%), hypofibrinogenemia (26. 3%) and liver dysfunction ( 63. 2 %) were observed. Four cases (21.1%) were found to be infected with EB virus. Hemophagocytosis was observed in bone marrow in all patients. Eight cases were survival during the follow-up and 7 cases were dead,4 cases lost follow-up. The median survival time was 4.7 months (range 0.3 to 39.8 months). Conclusion: HPS is an uncommon fatal disease and it has very complex clinical manifestations, aggressive course, poor prognosis and high death rate. A high index of suspicion is the critical factor for early diagnosis,and early treatment with immunosuppressant is warranted.
出处 《临床血液学杂志》 CAS 2016年第3期398-401,共4页 Journal of Clinical Hematology
关键词 噬血细胞综合征 发病机制 治疗 预后 hemophagocytic syndrome pathogenesis treatment prognosis
  • 相关文献

参考文献8

  • 1Janka GE,Lehmberg K.Hemophagocytic syndromesan update[J].Blood Rev,2014,28:135-142.
  • 2Iordan MB,Allen CE,Weitzman S,et al.How I treat hemophagocytic lymphohistiocytosis[J].Blood,2011,118:4041-4052.
  • 3Li F,Yang Y,Jin F,et al.Clinical characteristics and prognostic factors of adult hemophagocytic syndrome patients:a retrospective study of increasing awareness of a disease from a single-center in China[J].Orphanet J Rare Dis,2015,10:20.
  • 4Janka GE.Familial and acquired hemophagocytic lymphohistiocytosis[J].Eur J Pediatr,2007,166:95-109.
  • 5林宁晶,宋玉琴,郑文,涂梅峰,谢彦,王小沛,平凌燕,张晨,刘卫平,朱军.淋巴瘤相关噬血细胞综合征27例的临床特征及生存分析[J].肿瘤,2015,35(2):197-204. 被引量:8
  • 6Shabbir M,Lucas J,Lazarchick J,et al.Secondary hemophagocytic syndrome in adults:a case series of 18patients in a single institution and a review of literature[J].Hematol Oncol,2011,29:100-106.
  • 7Trottestam H,Home A,Arico M,et al.Histiocyte society chemoimmunotherapy for hemophagocytic lymphohistiocytosis:long-term results of HLH-94treatment protocol[J].Blood,2011,118:4577-4584.
  • 8Marsh RA,Allen CE,McClain KL,et al.Salvage therapy of refractory hemophagocytic lymphohistiocytosis with alemtuzumab[J].Pediatr Blood Cancer,2013,60:101-109.

二级参考文献21

  • 1陈捷,吴颖,田红.淋巴瘤相关性嗜血细胞综合征28例临床诊治分析[J].实用医学杂志,2007,23(17):2714-2716. 被引量:8
  • 2Janka GE, Lehmberg K .Hemophagocytic syndromes —an update[J]. Blood Rev, 2 014,28(4):135-142.
  • 3Henter JI, Horne AC, Arico M, ef al.HLH-2004: Diagnostic and therapeuticguidelines for hemophagocyticlymphohistiocytosisUl- Pediatr BloodCancer, 2007, 48(2):124-131.
  • 4Shipp MA. A predictive modelfor aggressive non-Hodgkin’slymphoma. The International Non-Hodgkin *s Lymphoma PrognosticFactors Project[J]. N Engl J Med, 1993,329(14):987-994.
  • 5Cheson BD, Pfistner B, Juweid ME,et a/. Revised response criteria formalignant lymphoma[J]. J Clin Oncol,2007, 25(5):579-586.
  • 6Lin N, Song Y, Zheng W, et a/.A prospective phase II study ofZ.-asparaginase-CHOP plus radiationin newly diagnosed extranodal NK/T-cell lymphoma, nasal typeL)]- JHematol Oncol, 201 3(6):44.
  • 7Yong W, Zheng W, Zhu J, et al./.-asparaginase in the treatment ofrefractory and relapsed extranodalNK/T-cell lymphoma, nasal type[J].Ann Hematol, 2009, 88(7):647-652.
  • 8Riviere S, Galicier L, Coppo P, et al.Reactive hemophagocytic syndromein adults: A multicenter retrospectiveanalysis of 162 patients[J]. Am J Med,2014,127(1 1):1 1 18-1 125.
  • 9Han AR, Lee HR, Park BB, eta/. Lymphoma-associated hemophagocytic syndrome:clinical features and treatmentoutcome[J]. Ann Hematol, 2007,86(7):493-498.
  • 10Han L, Li L, Wu J, et al. Clinicalfeatures and treatment ofnatural killer/T cel I lymphomaassociated with hemophagocyticsyndrome: comparison with otherT cell lymphoma associated withhemophagocytic syndromeLJ]. LeukLymphoma, 2014, 55(9):2048-2055.

共引文献7

同被引文献18

引证文献5

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部